Literature DB >> 32115864

Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure.

Pooja Dewan1, Alice Jackson1, Carolyn S P Lam2,3,4, Marc A Pfeffer5, Faiez Zannad6, Bertram Pitt7, Scott D Solomon5, John J V McMurray1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32115864     DOI： 10.1002/ejhf.1776

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  10 in total

Review 1.  Heart failure with mildly reduced ejection fraction: from diagnosis to treatment. Gaps and dilemmas in current clinical practice.

Authors:  Marta Cvijic; Yelena Rib; Suzana Danojevic; Crina Ioana Radulescu; Natia Nazghaidze; Panos Vardas
Journal:  Heart Fail Rev       Date:  2022-07-25       Impact factor: 4.654

Review 2.  Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender.

Authors:  Massimo Iacoviello; Rosanna Pugliese; Michele Correale; Natale Daniele Brunetti
Journal:  Curr Heart Fail Rep       Date:  2022-10-05

3.  Preserved ejection fraction and structural heart disease in 446 848 patients investigated with echocardiography.

Authors:  David Playford; Geoffrey Strange; Simon Stewart
Journal:  ESC Heart Fail       Date:  2020-12-22

Review 4.  Out with the Old and In with the New: Primary Care Management of Heart Failure with Preserved Ejection Fraction.

Authors:  Simon Stewart; Amy R Stewart; Laura Waite; Justin Beilby
Journal:  Card Fail Rev       Date:  2022-02-17

Review 5.  A year in heart failure: an update of recent findings.

Authors:  Lorenzo Stretti; Dauphine Zippo; Andrew J S Coats; Markus S Anker; Stephan von Haehling; Marco Metra; Daniela Tomasoni
Journal:  ESC Heart Fail       Date:  2021-12-16

6.  Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.

Authors:  Wanqian Yu; Hongzhou Zhang; Wen Shen; Fan Luo; Shuai Yang; Lujin Gan; Yuanbin Zhao; Pingping Yang; Qinghua Wu
Journal:  Front Cardiovasc Med       Date:  2022-09-08

Review 7.  Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction.

Authors:  Kanako Teramoto; Tiew-Hwa Katherine Teng; Chanchal Chandramouli; Jasper Tromp; Yasuhiko Sakata; Carolyn Sp Lam
Journal:  Card Fail Rev       Date:  2022-08-04

8.  Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.

Authors:  Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; João Pedro Ferreira; Martina Brueckmann; Edimar Bocchi; Michael Böhm; Vijay K Chopra; Nadia Giannetti; Tomoko Iwata; James L Januzzi; Sanjay Kaul; Ileana L Piña; Piotr Ponikowski; Ursula Rauch-Kröhnert; Sanjiv J Shah; Michele Senni; Mikhail Sumin; Subodh Verma; Jian Zhang; Stuart J Pocock; Faiez Zannad; Milton Packer; Stefan D Anker
Journal:  Circulation       Date:  2022-09-13       Impact factor: 39.918

9.  Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA).

Authors:  David Playford; Geoff Strange; David S Celermajer; Geoffrey Evans; Gregory M Scalia; Simon Stewart; David Prior
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-04-28       Impact factor: 6.875

10.  Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.

Authors:  Javed Butler; Milton Packer; Gerasimos Filippatos; Joao Pedro Ferreira; Cordula Zeller; Janet Schnee; Martina Brueckmann; Stuart J Pocock; Faiez Zannad; Stefan D Anker
Journal:  Eur Heart J       Date:  2022-02-03       Impact factor: 29.983
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.